Checkpoint Therapeutics Investor Relations Material
Latest events
Q1 2025
13 May, 2025
Q4 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Checkpoint Therapeutics Inc
Access all reports
Checkpoint Therapeutics Inc. is a biopharmaceutical company focused on developing immunotherapy and targeted treatments for cancer. The company specializes in monoclonal antibodies and small-molecule inhibitors designed to enhance the immune system’s ability to fight tumors. Its pipeline includes drug candidates for various cancers, advancing through clinical trials and regulatory approvals. The company is headquartered in Waltham, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Corporate Presentation
Checkpoint Therapeutics Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CKPT
Country
🇺🇸 United States